1. Home
  2. PRAX vs SCI Comparison

PRAX vs SCI Comparison

Compare PRAX & SCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$331.79

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Service Corporation International

SCI

Service Corporation International

HOLD

Current Price

$81.58

Market Cap

11.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
SCI
Founded
2015
1962
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
11.3B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
PRAX
SCI
Price
$331.79
$81.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
4
Target Price
$572.13
$98.00
AVG Volume (30 Days)
345.8K
1.1M
Earning Date
05-01-2026
04-29-2026
Dividend Yield
N/A
1.67%
EPS Growth
N/A
7.65
EPS
N/A
3.80
Revenue
N/A
$4,309,234,000.00
Revenue This Year
N/A
$4.03
Revenue Next Year
$6,395.88
$3.73
P/E Ratio
N/A
$21.47
Revenue Growth
N/A
2.93
52 Week Low
$28.79
$74.14
52 Week High
$354.87
$86.34

Technical Indicators

Market Signals
Indicator
PRAX
SCI
Relative Strength Index (RSI) 57.17 51.44
Support Level $282.49 $75.89
Resistance Level $327.65 $84.14
Average True Range (ATR) 17.60 1.86
MACD 2.86 0.18
Stochastic Oscillator 81.68 65.27

Price Performance

Historical Comparison
PRAX
SCI

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About SCI Service Corporation International

Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, Service Corp. provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. Service Corp. derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: